Desq Long
Sign in

Company

BIO-TECHNE Corp

TECH · CIK 0000842023

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 15,940 shares at $0 per share.

Reporting Person BAUMGARTNER ROBERT V · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0000914190-26-000139 · filed 2026-09-24 · View filing →

SEC FORM 4
$403,305.45

BIO-TECHNE Corp (TECH)

Disposition (code F) of 5,559 shares at $72.55 per share.

Reporting Person BAUMGARTNER ROBERT V · Transaction Code F

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0000914190-26-000139 · filed 2026-09-24 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 589 shares at $0 per share.

Reporting Person Herr Amy E. · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000113 · filed 2026-08-18 · View filing →

SEC FORM 4
$15,421.20

BIO-TECHNE Corp (TECH)

Disposition (code F) of 213 shares at $72.40 per share.

Reporting Person Herr Amy E. · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000113 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 5,423 shares at $0 per share.

Reporting Person Crouse Steven C. · Officer Title President - Diag & Spatial Bi · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000114 · filed 2026-08-18 · View filing →

SEC FORM 4
$140,962.80

BIO-TECHNE Corp (TECH)

Disposition (code F) of 1,947 shares at $72.40 per share.

Reporting Person Crouse Steven C. · Officer Title President - Diag & Spatial Bi · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000114 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 4,350 shares at $0 per share.

Reporting Person Bohnen Shane · Officer Title SVP - General Counsel · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000116 · filed 2026-08-18 · View filing →

SEC FORM 4
$97,233.20

BIO-TECHNE Corp (TECH)

Disposition (code F) of 1,343 shares at $72.40 per share.

Reporting Person Bohnen Shane · Officer Title SVP - General Counsel · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000116 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 6,416 shares at $0 per share.

Reporting Person Geist William · Officer Title PRESIDENT, PROTEIN SCIENCES · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000120 · filed 2026-08-18 · View filing →

SEC FORM 4
$143,062.40

BIO-TECHNE Corp (TECH)

Disposition (code F) of 1,976 shares at $72.40 per share.

Reporting Person Geist William · Officer Title PRESIDENT, PROTEIN SCIENCES · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000120 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 9,779 shares at $0 per share.

Reporting Person Hippel James · Officer Title CFO · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000121 · filed 2026-08-18 · View filing →

SEC FORM 4
$312,044.00

BIO-TECHNE Corp (TECH)

Disposition (code F) of 4,310 shares at $72.40 per share.

Reporting Person Hippel James · Officer Title CFO · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000121 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

BIO-TECHNE Corp (TECH)

Acquisition (code M) of 21,470 shares at $0 per share.

Reporting Person Kelderman Kim · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$783,440.40

BIO-TECHNE Corp (TECH)

Disposition (code F) of 10,821 shares at $72.40 per share.

Reporting Person Kelderman Kim · Officer Title Chief Executive Officer · Transaction Code F

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000914190-26-000122 · filed 2026-08-18 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Bio-Techne Corp (TECH)

Sale.

Filer April Delaney · Chamber House · District MD06 · Transaction Type Sale · Asset Type Stock

Traded Apr 8, 2026 · Disclosed May 6, 2026FILED +28 DAYS

Source: House Clerk PTR · 20034487 · filed 2026-05-06 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Bio-Techne Corp (TECH)

Sale.

Filer April Delaney · Chamber House · District MD06 · Transaction Type Sale · Asset Type Stock

Traded Mar 26, 2026 · Disclosed Apr 6, 2026FILED +11 DAYS

Source: House Clerk PTR · 20034299 · filed 2026-04-06 · View filing →